Novavax Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Novavax, Inc. (NVAX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-0.19-0.55-0.66-1.74-0.42-0.13-0.18
Depreciation & Amortization0.050.040.030.010.000.010.01
Stock Based Compensation0.050.090.130.180.130.000.00
Change in Working Capital0.05-0.38-0.361.730.26-0.02-0.02
Change in Accounts Receivable0.35-0.270.25-0.18-0.420.000.00
Change in Inventory0.01-0.07-0.48-0.010.000.000.00
Change in Accounts Payable-0.39-0.380.910.600.160.000.00
Change in Other Working Capital-0.020.000.000.140.000.000.00
Other Operating Activities0.000.070.440.140.110.02-0.01
Net Cash from Operating Activities-0.09-0.71-0.420.32-0.04-0.14-0.18
Investing Activities
Capital Expenditures-0.01-0.05-0.09-0.060.050.000.00
Acquisitions0.000.000.000.00-0.170.000.00
Purchases of Investments-0.380.000.000.00-0.160.000.00
Sales/Maturities of Investments0.00-0.010.000.16-0.160.040.03
Other Investing Activities0.190.000.000.000.000.020.00
Net Cash from Investing Activities-0.20-0.06-0.090.10-0.380.040.03
Financing Activities
Debt Repayment0.00-0.35-0.09-0.13-0.100.000.00
Common Stock Issued0.260.360.250.560.880.100.10
Other Financing Activities0.000.00-0.010.02-0.040.000.00
Net Cash from Financing Activities0.260.000.320.460.980.100.10
Summary
Effect of Forex Changes on Cash-0.010.000.00-0.010.000.000.00
Net Change in Cash-0.04-0.77-0.180.880.570.00-0.05
Cash at Beginning of Period0.581.351.530.650.080.080.14
Cash at End of Period0.55-0.771.351.530.650.080.08
Free Cash Flow-0.10-0.77-0.500.27-0.10-0.14-0.19
Supplemental Disclosures
Interest Paid0.020.020.020.020.010.010.01
Income Taxes Paid0.000.000.020.010.000.000.00